The Evaluation of Injection Site Pain and Adherence in Patients Switching From a Low To High Concentration Adalimumab (AVT-02) Across Multiple Indications.
Clinical trial NCT05913817 · COMPLETED
Trial details
- NCT number
- NCT05913817
- Sponsor
- Jamp Pharma Corporation
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2023-01-09
- Primary completion
- 2025-07-31
- Enrollment
- 324
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.